zandelisib
nordic group,mei,kyowa kirin
['bet', 'zandelisib', 'lymsm', 'emergent ', 'nordic']
on the other hand, toxicity does seem better than other pi3ki trials - is this zandelisib-specific or cohort-specific i wonder? may not be relevant given pause on zandelisib development outside of japan... #ash22 #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer